MedPath

广东宏远集团药业有限公司

Ownership
-
Established
1994-12-20
Employees
-
Market Cap
-
Website
www.hongyuanyaoye.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

33

NMPA:33

Drug Approvals

Sodium Fructose Diphosphate Injection

Product Name
果糖二磷酸钠注射液
Approval Number
国药准字H10950234
Approval Date
Jul 12, 2024
NMPA

Sodium Fructose Diphosphate Injection

Product Name
果糖二磷酸钠注射液
Approval Number
国药准字H10950233
Approval Date
Jul 12, 2024
NMPA

Hepatocyte Growth-promoting Factor Granules

Product Name
促肝细胞生长素颗粒
Approval Number
国药准字H10970411
Approval Date
Jul 12, 2024
NMPA

Mannatide Tablets

Product Name
甘露聚糖肽片
Approval Number
国药准字H20003716
Approval Date
Jul 8, 2024
NMPA

Ubidecarenone Capsules

Product Name
辅酶Q10胶囊
Approval Number
国药准字H19999256
Approval Date
Jul 8, 2024
NMPA

Pediatric Paracetamol,Atificial Cow-bezoar and Chlorphenamine Maleate Granules

Product Name
小儿氨酚黄那敏颗粒
Approval Number
国药准字H44024342
Approval Date
Jul 8, 2024
NMPA

Pantoprazole Sodium for Injection

Product Name
注射用泮托拉唑钠
Approval Number
国药准字H20066017
Approval Date
Dec 24, 2020
NMPA

Sodium Nitroprusside for Injection

Product Name
注射用硝普钠
Approval Number
国药准字H20064559
Approval Date
Dec 15, 2020
NMPA

Potassium Sodium Dehydroandrographolide Succinate for Injection

Product Name
注射用炎琥宁
Approval Number
国药准字H20046406
Approval Date
Apr 1, 2020
NMPA

Potassium Sodium Dehydroandrographolide Succinate for Injection

Product Name
注射用炎琥宁
Approval Number
国药准字H20046407
Approval Date
Mar 17, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.